VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM

A medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy and symptoms despite standard meds? Perhaps, a randomized trial suggests.
Medscape Medical News

source https://www.medscape.com/viewarticle/971484?src=rss